DocGo (DCGO) Competitors

DocGo logo
$5.54 -0.02 (-0.36%)
Closing price 02/14/2025 04:00 PM Eastern
Extended Trading
$5.43 -0.11 (-1.97%)
As of 02/14/2025 07:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DCGO vs. PACS, ADUS, ARDT, PGNY, WGS, NHC, VRDN, AGL, FTRE, and CDNA

Should you be buying DocGo stock or one of its competitors? The main competitors of DocGo include PACS Group (PACS), Addus HomeCare (ADUS), Ardent Health Partners (ARDT), Progyny (PGNY), GeneDx (WGS), National HealthCare (NHC), Viridian Therapeutics (VRDN), agilon health (AGL), Fortrea (FTRE), and CareDx (CDNA). These companies are all part of the "healthcare" industry.

DocGo vs.

DocGo (NASDAQ:DCGO) and PACS Group (NYSE:PACS) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, community ranking, media sentiment and analyst recommendations.

DocGo has a net margin of 4.35% compared to PACS Group's net margin of 0.00%. DocGo's return on equity of 8.90% beat PACS Group's return on equity.

Company Net Margins Return on Equity Return on Assets
DocGo4.35% 8.90% 5.72%
PACS Group N/A N/A N/A

56.4% of DocGo shares are held by institutional investors. 2.7% of DocGo shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

DocGo presently has a consensus price target of $6.10, indicating a potential upside of 10.11%. PACS Group has a consensus price target of $34.00, indicating a potential upside of 153.52%. Given PACS Group's higher probable upside, analysts plainly believe PACS Group is more favorable than DocGo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DocGo
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
PACS Group
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.88

PACS Group has higher revenue and earnings than DocGo.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DocGo$694.97M0.81$6.86M$0.2819.79
PACS Group$3.11B0.66$112.87MN/AN/A

DocGo received 22 more outperform votes than PACS Group when rated by MarketBeat users. However, 95.83% of users gave PACS Group an outperform vote while only 75.00% of users gave DocGo an outperform vote.

CompanyUnderperformOutperform
DocGoOutperform Votes
45
75.00%
Underperform Votes
15
25.00%
PACS GroupOutperform Votes
23
95.83%
Underperform Votes
1
4.17%

In the previous week, PACS Group had 3 more articles in the media than DocGo. MarketBeat recorded 4 mentions for PACS Group and 1 mentions for DocGo. PACS Group's average media sentiment score of 0.24 beat DocGo's score of 0.22 indicating that PACS Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DocGo
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
PACS Group
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

DocGo beats PACS Group on 8 of the 15 factors compared between the two stocks.

Get DocGo News Delivered to You Automatically

Sign up to receive the latest news and ratings for DCGO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DCGO vs. The Competition

MetricDocGoHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$565.36M$966.48M$5.76B$9.22B
Dividend YieldN/A2.01%5.27%4.00%
P/E Ratio19.7936.0726.2019.44
Price / Sales0.814.04456.5777.34
Price / Cash23.0625.3046.0638.90
Price / Book1.892.967.355.05
Net Income$6.86M-$3.49M$3.19B$222.81M
7 Day Performance1.84%13.27%1.69%1.29%
1 Month Performance32.85%11.88%4.13%1.52%
1 Year Performance50.14%125.77%22.24%16.53%

DocGo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DCGO
DocGo
1.3161 of 5 stars
$5.54
-0.4%
$6.10
+10.1%
+50.1%$565.36M$694.97M19.794,164
PACS
PACS Group
4.0963 of 5 stars
$14.18
+0.6%
$34.00
+139.7%
N/A$2.16B$3.11B0.0032,433
ADUS
Addus HomeCare
4.7354 of 5 stars
$116.46
+0.3%
$134.22
+15.3%
+20.1%$2.11B$1.13B26.6534,846Upcoming Earnings
Short Interest ↓
ARDT
Ardent Health Partners
N/A$14.74
-1.7%
$21.55
+46.2%
N/A$2.10B$5.71B0.0024,200
PGNY
Progyny
2.3416 of 5 stars
$22.35
+2.0%
$25.50
+14.1%
-45.2%$1.90B$1.09B38.54310
WGS
GeneDx
1.3098 of 5 stars
$68.15
+14.5%
$70.67
+3.7%
+1,411.9%$1.87B$202.57M-21.911,200
NHC
National HealthCare
N/A$100.71
+1.0%
N/AN/A$1.55B$1.14B12.6213,123Dividend Announcement
VRDN
Viridian Therapeutics
2.3806 of 5 stars
$17.98
+1.2%
$35.70
+98.6%
-11.8%$1.42B$310,000.00-4.1750
AGL
agilon health
2.2945 of 5 stars
$3.29
-1.4%
$4.03
+22.6%
-51.8%$1.35B$4.32B-3.491,117Short Interest ↓
FTRE
Fortrea
2.4075 of 5 stars
$15.07
+1.1%
$23.30
+54.6%
-58.0%$1.35B$3.11B-4.4118,000
CDNA
CareDx
3.23 of 5 stars
$24.91
+11.2%
$28.33
+13.7%
+201.4%$1.34B$312.78M-9.23740Positive News
High Trading Volume

Related Companies and Tools


This page (NASDAQ:DCGO) was last updated on 2/17/2025 by MarketBeat.com Staff
From Our Partners